Dec. 10 at 3:38 PM
$ACHC I have lost more money than I care to admit on this name, but when you are trading at 5-5.5x next year's EBITDA In healthcare services and your book value Is over 2x the current price, you just cover your eyes and buy. What's concerning Is the overhang of litigation has made It Impossible for management to follow through with their buyback authorization - at current prices they have the ability to buy back almost 20% of the float. They just don't have the wiggle room after dealing with shareholder suit settlement and declining profitability (Increases leverage ratio). If they came out today and said - we've decided to stop all new capex, harvest cash, buy back stock, etc - this thing would be trading
$25-
$30 In a heartbeat.